Streamlining processes like trial site selection and FDA documentation can make a meaningful difference in development ...

The program taps into several OpenAI models and can be used across a wide range of therapeutic indications. Both Big Pharma ...

Integrating novel technologies in drug development and quality control, such as big data analytics, artificial intelligence, ...

Drug Designing Tools Market. The global drug designing tools market is poised for significant expansion, anticipated to grow ...

Design and digital innovation can play a vital role in renewing audiences’ trust in pharma brands and helping engage Gen Z, says Troy Polsley of creative agency Minds + Assembly Americans trust pharma ...

While A.I. promises breakthroughs, industry leaders warn that transparency and patient safety must remain front and center.

Tokyo, Japan and London and Cardiff, UK, 5 November 2024 – Nxera Pharma (“Nxera ... s generative AI antibody design expertise, including its proprietary machine-learning-generated ...

Nxera Pharma, previously known as Sosei Heptares or the Sosei Group, has entered a collaboration and licensing agreement with Antiverse to design antibodies for G-protein coupled receptors (GPCRs).

NTU Singapore is introducing two new undergraduate degree programmes in robotics and advanced chemical and pharmaceutical manufacturing in August 2025. The two programmes are designed to meet an ...

Tokyo, Japan and London and Cardiff, UK, 5 November 2024 – Nxera Pharma (“Nxera”; TSE 4565) – formerly known as Sosei Group or Sosei Heptares – ...

Nxera Pharma & Antiverse collaborate to design novel GPCR-targeted antibody therapeutics using generative AI: Tokyo, Japan Wednesday, November 6, 2024, 13:00 Hrs [IST] Nxera Pharm ...